DENTSPLY SIRONA INC.

37.0 +0.55 (+1.48%) Buy

XRAY continues to mint money for it's investors

13 min read

DENTSPLY SIRONA INC. outperformed the broader market on Tuesday. It increased by +1.48% to close at 37.0. It is currently trading -45% below it's 52 week high of 68.3.

[Themes containing XRAY]

XRAY is currently in a bullish trend. Over the last three months trading long signals has not been a profitable strategy for XRAY's investors in general. However, this strategy had significantly lower risk when compared to Buy-and-Hold investing (which returned -4.49%). It is therefore better to tread with caution in the current uptrend by limiting your allocation to XRAY.

Trend

XRAY has been outperforming the SP500 index in recent time. It showed significant underperformance (compared to the SP500 index) from 29 Feb, 2016 to 4 Oct, 2018. Over the last 2 years 11 months and 7 days, XRAY underperformed the SP500 index on 50% days. Which indicates that on days XRAY underperforms the SP500 index, it's performance is marginally worse than on the days it outperforms the SP500 index.

During the last three months XRAY was mostly loss making and delivered on average -0.07% per day. It's best return during this period (of +2.82%) was on Wednesday, 7 Nov, 2018. While it's worst loss in the same period (of -3.78%) was on Thursday, 18 Oct, 2018. The longest stort-term trend during this period was 6 losing days, which started on 27 Sep, 2018 and ended on 4 Oct, 2018. This bearish trend lost -4.92% of investor capital.

During the last year XRAY had 3 profitable months and 9 loss making months. XRAY returned profits in fewer months than SP500 index. XRAY was also a more risky investment than SP500 index as it's worst month in the last year, Aug 2018, returned -17.02% compared to -7.28% returned by SP500 index in Oct 2018. XRAY had a longer winning streak of losing months than SP500 index. It went down in 3 straight months (from Jan 2018 to Mar 2018) during which period it delivered -27.5%. It is interesting to note that both XRAY and SP500 index significantly outperform during months when quarterly/annual results are announced.

I have probably purchased fifty 'hot tips' in my career, maybe even more. When I put them all together, I know I am a net loser.
-- Charles Schwab

XRAY is currently seeing overall fall in volatility. In comparison, the SP500 index is seeing increase in volatility. During the last three months, there was a significant surge in XRAY's volatility from 24 Sep, 2018 to 12 Nov, 2018. While there was a significant surge in the SP500 index's volatility from 13 Sep, 2018 to 29 Oct, 2018.

Advanced/professional short-term investors should note that XRAY has significant positive skewness in it's return distribution. This indicates that investors can expect XRAY to recover from drawdowns quickly. Which makes XRAY a good candidate for investing on short-term bullish trends or even counter-trends hoping for a pull-back.

SP500 index has more chance of extreme outcomes than XRAY. Therefore, SP500 must receive a lower allocation than XRAY in your portfolio. XRAY usually has shorter drawdown period than the SP500 index.

On a general note (since you are interested in XRAY), three large cap instruments that deserve special mention are CSCO, MSFT and PFE. They have all outperformed the market and must be closely watched for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}} 
 
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter